Trials / Completed
CompletedNCT02224937
MELATOX: Evaluation of Percutaneous Dissolvement of Melatonin When Used as Sunscreen; a Randomized, Placebo Controlled, Double-blind Crossover Study on Healthy Volunteers.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Zealand University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the percutaneous transportation and pharmacokinetics of melatonincream 12,5% when used on 80% of the body area. A test battery consisting of blood, saliva, urine samples at 1,2,3,4,5,6,7,8,12,24 and 36 hours after cream application. Cognitive parameters are investigated using KSS, FTT and CRT tests at above mentioned time points.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Melatonin | |
| DRUG | Placebo |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2014-02-01
- First posted
- 2014-08-25
- Last updated
- 2014-11-17
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02224937. Inclusion in this directory is not an endorsement.